iPhone | iPad
Android
Huawei
Pecker is a key witness in the case against the former US president, who is accused of falsifying business records to cover up hush-money payment
KT APPDOWNLOAD
15,000 volunteers to take part in Covid-19 vaccine trial in Abu Dhabi
Sheikh Abdullah bin Mohammed Al Hamed, chairman of the Department of Health - Abu Dhabi (DoH), was the first volunteer who received the vaccine earlier today.
Abu Dhabi - The clinical trial will be open to individual volunteers aged 18 to 60, who are living in Abu Dhabi city and Al Ain.
- ???? ?????? ???????? (@admediaoffice) July 16, 2020
During the process - which is being carried out by health practitioners from Abu Dhabi Health Services (Seha) - the volunteers are required to be available for follow-ups.
Seha and G42 Healthcare are working towards having a minimum of 5,000 volunteers in the first stage of the programme. Five Seha-run clinics in Abu Dhabi and Al Ain, as well as a mobile clinic, have been designated for the programme.
- ???? ?????? ???????? (@admediaoffice) July 16, 2020
- ???? ?????? ???????? (@admediaoffice) July 16, 2020
"The UAE has been chosen as the preferred destination for the trials because of its diverse population of more than 200 nationalities, allowing for robust research across multiple enthnicities and increasing its feasiblity for global application," Ashish Koshy, CEO of G42 Healthcare, said on Thursday during a virtual Press briefing in Abu Dhabi.
"Also, the UAE has been at the forefront of fighting the pandemic since the outbreak and has participated in research for trying to find the Covid-19 vaccine." Koshy added that G42 Healthcare will be running the clinical operations for the procedure.
Phase 3 is the last stage of a vaccine's clinical trials. It evaluates the safety and effectiveness of the vaccine on a larger segment of people. If it is confirmed safe and effective throughout the process, the vaccine enters the large-scale manufacturing phase.
The trials in Abu Dhabi follows the success of the first two phases conducted in China, which saw 100 per cent of volunteers generate antibodies after two doses in 28 days.
Dr Nawal Ahmed Mohamed Al Kaabi, UAE principal investigator of Sheikh Khalifa Medical City CMO and chairperson of the National Covid-19 Clinical Management Committee, said a protocol is in place for the selection of the 15,000 trial participants.
"It will include Emiratis and residents of various nationalities and they should be in good health and not suffering from chronic diseases. Also, they should have no history of having been infected with Covid-19," said Al Kaabi.
Patients will be given two doses within a period of three weeks and there will be monthly follow-ups for a year, she explained.
"The volunteering patiets will not be admitted in hospitals but we shall be monitoring them closely. There will be regular face-to-face meetings."
With the success of the previous stages of clinical trials, "we don't expect any risks of volunteering patients getting infected with Covid-19 or other side-effects in this trial phase", she added.
ismail@khaleejtimes.com
More news from
The oil and gas conglomerate and Fifa, the world governing body, sign major sponsorship agreement
Toomaj Salehi risks being hanged after the conviction on the Shariah charge of "corruption on Earth" by a Revolutionary Court
Aid groups warn any invasion would add to already-catastrophic conditions for Gaza's 2.4 million people
The American they will face Australia and Serbia on July 15 and July 17 as part of their preparation for the Paris Olympic Games
The leaders emphasise that the deal to release the hostages would bring an immediate and prolonged ceasefire in Gaza
Dubai-based Sumit Augustine has had a philosophical approach towards spending
The regional upswing also defies oil production cutbacks
